Product Images Vabysmo
View Photos of Packaging, Labels & Appearance
- Figure A - faricimab 01
- Figure B - faricimab 02
- Figure C - faricimab 03
- Figure D - faricimab 04
- Figure E - faricimab 05
- Figure F - faricimab 06
- Figure G - faricimab 07
- Figure H - faricimab 08
- Figure I - faricimab 09
- Figure J - faricimab 10
- Figure K - faricimab 11
- Figure L - faricimab 12
- Figure 1 - faricimab 13
- Figure 2 - faricimab 14
- Figure 3 - faricimab 15
- Figure 4 - faricimab 16
- PRINCIPAL DISPLAY PANEL - 6 mg Vial Carton - faricimab 17
Product Label Images
The following 17 images provide visual information about the product associated with Vabysmo NDC 50242-096 by Genentech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - faricimab 13

The text describes the mean change in BCVA (a visual acuity measurement) in ETDRS letters over a period of a few weeks in a study where one group received VABYSMO (458 individuals) and another received Afbercept (451 individuals). Unfortunately, no further information is available.*
PRINCIPAL DISPLAY PANEL - 6 mg Vial Carton - faricimab 17

This text is a description of a medication for intravitreal injection. The medication is called "faricimab-svoa" and is contained in a single-dose vial. The vial contains 6mg of the medication, which is a 0.05mL solution of 120mg/mL. The package includes one single-dose vial and one transfer filter needle from Genentech. The user is advised to discard any unused portion. The National Drug Code (NDC) for the medication is 50242-096-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.